Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
437.67
+1.08 (+0.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
734,230
Open
437.38
Bid (Size)
432.63 (40)
Ask (Size)
440.00 (400)
Prev. Close
436.59
Today's Range
435.45 - 441.00
52wk Range
362.50 - 510.77
Shares Outstanding
259,428,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy?
↗
April 21, 2026
We'll know more about the company's medium-term prospects by the end of the year.
Via
The Motley Fool
2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term
↗
April 19, 2026
Vertex Pharmaceuticals has given Mirum Pharmaceuticals the blueprint for success in rare diseases.
Via
The Motley Fool
Performance
YTD
-3.2%
-3.2%
1 Month
-3.0%
-3.0%
3 Month
-1.0%
-1.0%
6 Month
+2.7%
+2.7%
1 Year
-8.3%
-8.3%
More News
Read More
Is Vertex Pharmaceuticals' Empire in Trouble?
↗
April 16, 2026
Via
The Motley Fool
1 S&P 500 Stock on Our Watchlist and 2 Facing Challenges
April 16, 2026
Via
StockStory
Topics
Stocks
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Presents a Compelling Growth and Technical Setup
↗
April 03, 2026
Via
Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Prime GARP Investment
↗
March 28, 2026
Via
Chartmill
Trump's Team Says Don't Worry About Rising Inflation. Here Are 3 Stocks to Buy If They're Wrong.
↗
April 14, 2026
Via
The Motley Fool
Topics
Economy
Government
Is This Biotech Stock Your Best Shot at Building a Millionaire-Making Position?
↗
April 07, 2026
Via
The Motley Fool
Topics
ETFs
Vertex to Announce First Quarter 2026 Financial Results on May 4th
April 06, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
April 02, 2026
Via
StockStory
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States
April 01, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Biotech Defies Gravity: Sarepta and Corcept Lead Midday Healthcare Rally Amidst Market Volatility
March 31, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Stocks
1 Cash-Producing Stock with Promising Prospects and 2 We Turn Down
March 30, 2026
Via
StockStory
Prediction: The Trump Bull Market Is About to End -- but These Stocks Will Rise Anyway
↗
March 28, 2026
Via
The Motley Fool
Topics
Economy
Energy
Government
2 Stocks I Plan to Hold for the Next 20 Years
↗
March 27, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds
March 27, 2026
Via
StockStory
Where Will Vertex Pharmaceuticals Be in 1 Year?
↗
March 25, 2026
Via
The Motley Fool
CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now?
↗
March 23, 2026
Via
The Motley Fool
New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST
March 21, 2026
Via
ACCESS Newswire
Vertex Pharmaceuticals (VRTX): The Evolution of a Biotech Powerhouse in 2026
March 20, 2026
Via
Finterra
Topics
Intellectual Property
Is CRISPR Therapeutics Stock a Buy Now?
↗
March 20, 2026
Via
The Motley Fool
My Top 3 Drug Stocks for March 2026
↗
March 20, 2026
Via
The Motley Fool
Topics
Intellectual Property
Best Growth Stock to Buy Right Now: Eli Lilly vs. Vertex Pharmaceuticals
↗
March 19, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks
March 17, 2026
Via
StockStory
Topics
Artificial Intelligence
1 Momentum Stock to Research Further and 2 We Ignore
March 16, 2026
Via
StockStory
Frequently Asked Questions
Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 437.67
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 04/22/26 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 113.54B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 114B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.